1014 related articles for article (PubMed ID: 25964570)
101. Strong subsite-specific variation in detecting advanced adenomas by fecal immunochemical testing for hemoglobin.
Brenner H; Niedermaier T; Chen H
Int J Cancer; 2017 May; 140(9):2015-2022. PubMed ID: 28152558
[TBL] [Abstract][Full Text] [Related]
102. Quantitative colonoscopic evaluation of relative efficiencies of an immunochemical faecal occult blood test and a sensitive guaiac test for detecting significant colorectal neoplasms.
Rozen P; Levi Z; Hazazi R; Waked A; Vilkin A; Maoz E; Birkenfeld S; Niv Y
Aliment Pharmacol Ther; 2009 Feb; 29(4):450-7. PubMed ID: 19035980
[TBL] [Abstract][Full Text] [Related]
103. DIAGNOSTIC ACCURACY OF ONE SAMPLE OR TWO SAMPLES QUANTITATIVE FECAL IMMUNOCHEMICAL TESTS FOR INTESTINAL NEOPLASIA DETECTION.
Mattar R; Marques SB; Minata MK; Silva-Etto JMKD; Sakai P; DE Moura EGH
Arq Gastroenterol; 2020; 57(3):316-322. PubMed ID: 32935747
[TBL] [Abstract][Full Text] [Related]
104. Faecal haemoglobin concentration influences risk prediction of interval cancers resulting from inadequate colonoscopy quality: analysis of the Taiwanese Nationwide Colorectal Cancer Screening Program.
Chiu SY; Chuang SL; Chen SL; Yen AM; Fann JC; Chang DC; Lee YC; Wu MS; Chou CK; Hsu WF; Chiou ST; Chiu HM
Gut; 2017 Feb; 66(2):293-300. PubMed ID: 26515543
[TBL] [Abstract][Full Text] [Related]
105. A higher detection rate for colorectal cancer and advanced adenomatous polyp for screening with immunochemical fecal occult blood test than guaiac fecal occult blood test, despite lower compliance rate. A prospective, controlled, feasibility study.
Levi Z; Birkenfeld S; Vilkin A; Bar-Chana M; Lifshitz I; Chared M; Maoz E; Niv Y
Int J Cancer; 2011 May; 128(10):2415-24. PubMed ID: 20658527
[TBL] [Abstract][Full Text] [Related]
106. Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer.
Dinh T; Ladabaum U; Alperin P; Caldwell C; Smith R; Levin TR
Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1158-66. PubMed ID: 23542330
[TBL] [Abstract][Full Text] [Related]
107. Colonoscopy vs. Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM): Rationale for Study Design.
Dominitz JA; Robertson DJ; Ahnen DJ; Allison JE; Antonelli M; Boardman KD; Ciarleglio M; Del Curto BJ; Huang GD; Imperiale TF; Larson MF; Lieberman D; O'Connor T; O'Leary TJ; Peduzzi P; Provenzale D; Shaukat A; Sultan S; Voorhees A; Wallace R; Guarino PD
Am J Gastroenterol; 2017 Nov; 112(11):1736-1746. PubMed ID: 29016565
[TBL] [Abstract][Full Text] [Related]
108. Immunological fecal occult blood test vs. serum ferritin for detection of colorectal neoplasia in high risk asymptomatic population.
Sobrino-Cossío S; Fenocchi E; Hernández-Guerrero A; Alonso-Lárraga JO; De la Mora-Levy JG; Larracilla-Salazar I
Rev Gastroenterol Mex; 2011; 76(3):191-8. PubMed ID: 22041307
[TBL] [Abstract][Full Text] [Related]
109. Factors associated with false-positive and false-negative fecal immunochemical test results for colorectal cancer screening.
Wong MC; Ching JY; Chan VC; Lam TY; Luk AK; Ng SS; Sung JJ
Gastrointest Endosc; 2015 Mar; 81(3):596-607. PubMed ID: 25293827
[TBL] [Abstract][Full Text] [Related]
110. A Risk-Scoring System Combined With a Fecal Immunochemical Test Is Effective in Screening High-Risk Subjects for Early Colonoscopy to Detect Advanced Colorectal Neoplasms.
Chiu HM; Ching JY; Wu KC; Rerknimitr R; Li J; Wu DC; Goh KL; Matsuda T; Kim HS; Leong R; Yeoh KG; Chong VH; Sollano JD; Ahmed F; Menon J; Sung JJ;
Gastroenterology; 2016 Mar; 150(3):617-625.e3. PubMed ID: 26627608
[TBL] [Abstract][Full Text] [Related]
111. Fecal occult blood testing in a general medical clinic: comparison between guaiac-based and immunochemical-based tests.
Ko CW; Dominitz JA; Nguyen TD
Am J Med; 2003 Aug; 115(2):111-4. PubMed ID: 12893396
[TBL] [Abstract][Full Text] [Related]
112. A combination of clinical risk stratification and fecal immunochemical test results to prioritize colonoscopy screening in asymptomatic participants.
Aniwan S; Rerknimitr R; Kongkam P; Wisedopas N; Ponuthai Y; Chaithongrat S; Kullavanijaya P
Gastrointest Endosc; 2015 Mar; 81(3):719-27. PubMed ID: 25708760
[TBL] [Abstract][Full Text] [Related]
113. Performance characteristics and comparison of two immunochemical and two guaiac fecal occult blood screening tests for colorectal neoplasia.
Rozen P; Knaani J; Samuel Z
Dig Dis Sci; 1997 Oct; 42(10):2064-71. PubMed ID: 9365136
[TBL] [Abstract][Full Text] [Related]
114. Predictive power of quantitative and qualitative fecal immunochemical tests for hemoglobin in population screening for colorectal neoplasm.
Huang Y; Li Q; Ge W; Cai S; Zhang S; Zheng S
Eur J Cancer Prev; 2014 Jan; 23(1):27-34. PubMed ID: 23942476
[TBL] [Abstract][Full Text] [Related]
115. Fecal MicroRNA-Based Algorithm Increases Effectiveness of Fecal Immunochemical Test-Based Screening for Colorectal Cancer.
Duran-Sanchon S; Moreno L; Gómez-Matas J; Augé JM; Serra-Burriel M; Cuatrecasas M; Moreira L; Serradesanferm A; Pozo À; Grau J; Pellisé M; Gironella M; Castells A
Clin Gastroenterol Hepatol; 2021 Feb; 19(2):323-330.e1. PubMed ID: 32113893
[TBL] [Abstract][Full Text] [Related]
116. Replacing the Guaiac Fecal Occult Blood Test With the Fecal Immunochemical Test Increases Proportion of Individuals Screened in a Large Healthcare Setting.
Akram A; Juang D; Bustamante R; Liu L; Earles A; Ho SB; Wang-Rodriguez J; Allison JE; Gupta S
Clin Gastroenterol Hepatol; 2017 Aug; 15(8):1265-1270.e1. PubMed ID: 28167157
[TBL] [Abstract][Full Text] [Related]
117. A True Positive and a False Negative? The Dilemma of Negative Colonoscopy After a Positive Fecal Occult Blood Test.
Hunt JS; Cock C; Symonds EL
Dig Dis Sci; 2022 May; 67(5):1843-1849. PubMed ID: 33939150
[TBL] [Abstract][Full Text] [Related]
118. Quantitative immunochemical fecal occult blood test for neoplasia in colon cancer screening.
Yuan SY; Wu W; Fu J; Lang YX; Li JC; Guo Y; Wang YN; Qian JM; Li JN
J Dig Dis; 2019 Feb; 20(2):78-82. PubMed ID: 30714346
[TBL] [Abstract][Full Text] [Related]
119. Repeated screening with fecal immunochemical tests reduced the incidence of colorectal cancers in Saga, Japan.
Sakata N; Sakata Y; Shimoda R; Sakata H; Iwakiri R; Fujimoto K; Mizuguchi M; Irie H; Shimoda Y; Noshiro H
Hepatogastroenterology; 2014; 61(133):1224-8. PubMed ID: 25436287
[TBL] [Abstract][Full Text] [Related]
120. [The optimal thresholds of the quantitative fecal immunochemical test for opportunistic screening of colorectal neoplasia].
Kang Q; Li N; Su H; Yang L; He YQ; Jia KM; Wang X; Jin P; Sheng JQ
Zhonghua Yi Xue Za Zhi; 2020 Mar; 100(10):767-770. PubMed ID: 32192290
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
